Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

Author： Taghdisi Seyed Mohammad Abnous Khalil Mosaffa Fatemeh Behravan Javad

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.18, Iss.4, 2010-05, pp. : 277-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 340-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery

Current Drug Targets, Vol. 19, Iss. 3, 2018-02 ,pp. : 248-258

Bentham Science Publishers

Access to resources Recommend Favorite

Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia

By Thomas Xavier

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 871-878

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatments in Acute Lymphoblastic Leukemia

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 19-31

Bentham Science Publishers

Access to resources Recommend Favorite